8 firms writing Biotech checks in Austin, led by Future Ventures, Breakout Ventures, Compound — ranked by verified deal count with the companies behind each.
Biotech in Austin accounts for 3 tracked companies with verified cap-table data, 3 of which disclose round sizes totalling $623M. The median disclosed raise is $173M, and the largest is Ollin Biosciences at $330M, ahead of MicroTransponder ($173M) and Paradromics ($120M).
The names that recur most often on these biotech cap tables are ARCH Venture Partners (1 company), Mubadala Capital (1 company), Monograph Capital (1 company), Wellington Management (1 company), TCGX (1 company), J.P. Morgan Life Sciences Private Capital (1 company). By latest disclosed round, the market skews Series B (1), Series E (1), Series A (1).
All research · Investor directory · Company funding database · Fundraising library